Refractive Surgery News

SAN FRANCISCO —Medical treatments for addressing presbyopia are on the horizon, with two approaches currently being studied, according to a speaker here.

SAN FRANCISCO — Surgeons have many options for controlling pain and inflammation following refractive surgery, William B. Trattler, MD, said in a presentation at Refractive Subspecialty Day at the American Academy of Ophthalmology annual meeting.

SAN FRANCISCO — Elad Kedar, CEO of Orasis Pharmaceuticals, discusses results of a phase 2b trial of the company’s CSF-1 eye drop formulation for presbyopia correction at the Ophthalmology Innovation Summit preceding the American Academy of Ophthalmology annual meeting. Positive safety, durability and efficacy results were demonstrated, he said.

SAN FRANCISCO — At the Ophthalmology Innovation Summit preceding the American Academy of Ophthalmology annual meeting, Yari Mitchell, chief business development officer at AcuFocus, discusses the IC-8 IOL, which combines a hydrophobic IOL with an embedded mini-ring to create a reduced aperture that improves range of vision. A recent Australian study shows practices are using the lens for a diverse range of patient needs, she said.

Bausch + Lomb has entered into a licensing agreement with Tatvum Research for the worldwide commercial rights to new IOL designs that will be used in the enVista IOL family, according to a press release.

PARIS — At the European Society of Cataract and Refractive Surgeons meeting, Schwind eye-tech-solutions launched the ATOS femtosecond laser, with capabilities for both femtoLASIK and innovative lenticule extraction with the SmartSight technology.

Jack S. Parker, MD, PhD, and colleagues at Parker Cornea in Birmingham, Alabama, demonstrate a surgical technique for implantation of CorneaGen’s Intacs segments for treatment of moderate keratoconus.

PARIS — At the European Society of Cataract and Refractive Surgeons meeting, Emilio Torres-Netto, MD, speaks about a new laser ablation profile that reduces the inflammatory response after PRK, based on preclinical experiments and genetic analyses to see how different ablation profiles affect corneal tissue. This research earned a best poster presentation award at the meeting.

PARIS — Preliminary results with the Artis Symbiose IOL for presbyopia look promising, according to several speakers at the Cristalens International Symposium held during the European Society of Cataract and Refractive Surgeons meeting. This new concept IOL technology consists of two complementary profiles, one optimized for near and the other for intermediate vision.

PARIS — At the European Society of Cataract and Refractive Surgeons meeting, Alessandro Mularoni, MD, speaks about a new sulcus-fixated supplementary IOL by Rayner, trifocal in the center and monofocal in the periphery, designed as an additional option for pseudophakic patients who wish to improve intermediate and near vision. His 10-month results within the European study show interesting outcomes.